GlaxoSmithKline places its shingles vaccine ... shot in all territories other than BioNTech's home market of Germany, Turkey and certain other developing countries. "Adults aged 50 years and ...

Visitors to Columbia’s antique shops, river trail and Turkey Hill Experience will no longer have to leave town to find a ...

Astellas also has rights to the drug in Japan – where it also approved and on sale – as well as Turkey, Russia ... has provided an opportunity for GSK and Akebia to beat FibroGen and AZ ...

Turkey has begun exporting around 15,000 tonnes of eggs to the ... The Government of Canada has secured an initial supply of 500,000 doses of GSK's bird flu vaccine to protect individuals most at risk ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...

Now, GSK is ready to play catch-up after nabbing its own FDA approval. The FDA approved the British drugmaker's Penmenvy vaccine to protect people ages 10 to 25 against meningococcal serogroups A ...

GSK's revenue and EPS exceeded my expectations and those of analysts, thanks to the strong performance of its oncology and HIV franchises. So, Ojjaara/Omjjara sales amounted to $150 million in the ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Hedge fund Citadel has made a £305mn bet against drugmaker GSK, the biggest short position against the ...

CDC vaccine advisors are set to discuss recommendations for the vaccine on Feb. 26. The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 ...

Tony Wood, Chief Scientific Officer, GSK, said: "We are excited about the opportunities ahead to help improve meningococcal vaccination coverage in the United States, especially for IMD caused by ...